70 new approved treatments For 20+ tumor types 500+ companies ~600new molecules Regulatory process & timing Regulatory/ Go...
Upcoming SlideShare
Loading in …5
×

The State of Oncology Innovation

10,127 views

Published on

New science is redefining cancer as a large number of narrowly defined diseases and bringing therapeutic options to an expanded number of patients. With the rapid growth in the oncology treatment landscape, health systems are struggling to adapt and embrace the evolution—including regulatory systems, diagnostic infrastructure, treatment providers and financing mechanisms. These challenges will require urgent attention in light of the strong near-term pipeline of clinically distinctive therapies and new programs that are galvanizing research efforts to change the trajectory for cancer.

Read the full report >> http://imsh.co/2axszmt

Published in: Healthcare
0 Comments
3 Likes
Statistics
Notes
no profile picture user

  • Be the first to comment

No Downloads
Views
Total views
10,127
On SlideShare
0
From Embeds
0
Number of Embeds
9,060
Actions
Shares
0
Downloads
12
Comments
0
Likes
3
Embeds 0
No embeds

No notes for slide

The State of Oncology Innovation

  1. 1. 70 new approved treatments For 20+ tumor types 500+ companies ~600new molecules Regulatory process & timing Regulatory/ Government Clinicians FinanceHospitals PayersPatients R&D Infrastructure Reimbursement Manufacturer registration Oncology Innovation The State of Breaking down the most fertile period of oncology research and development in history. WHY ONLY 6 COUNTRIES? LEADERS IN TREATMENT Embrace the Evolution Patient Access Growth Drivers Engaged in drug development globally Late stage development to treat cancers like breast, ovarian & prostate years 5 Treatment Innovation Surge Change Cancer Treatment Trajectory Full 2016 issue of the Global Oncology Trends report —->www.theimsinstitute.org Working Together To 9.5yrs (2015) 10.25yrs (2013) Patent to approval in U.S. New science is redefining cancer as a large number of narrowly defined diseases and yielding therapeutic options for a growing number of patients. Health systems are struggling to adapt.

×